BIOPIXLAR | Print Tissue as Nature Intended

Oct 25, 2019 | Projects

BIOPIXLAR ®
Print Tissue as Nature Intended

ABOUT

[/vc_column_text][/vc_column][vc_column width=”6/12″][vc_column_text]–

CLIENT: [/vc_column_text][vc_column_text]Fluicell is a public biotech company providing platforms to investigate cell behavior like never before. The company is a world leader and pioneer in open-volume microfluidics for the life sciences, and holds a strong IP and patent position with five different patent families in the estate.[/vc_column_text][/vc_column][vc_column width=”6/12″][vc_column_text]–

SERVICE: [/vc_column_text][vc_column_text]Our graphic design and scientific illustration team explains with highly detailed and crafted drawings how Biopixlar® works to build a tissue model by printing one cell at the time in order to reproduce the complex composition of human tissues, the bioprinting techniques also need to enable printing cells in a precise and controlled manner.[/vc_column_text][/vc_column][vc_column][us_separator][vc_column_text]

BIOPIXLAR –  A scientific illustration

In this case the graphic design for scientific illustration allows the company to show its technology at a glance in one single image and it also grabs the attention of the users in its corporate website.[/vc_column_text][us_separator][us_image image=”17176″ size=”full” align=”center”][us_separator][vc_column_text]Our scientific illustration solution can be also embedded into powerpoint presentations, websites and pdf´s documents for mobile devices.

Fluicell has developed Biopixlar, a game-changing bioprinting platform capable of producing tissue models by printing at the level of individual cells without a need of gel matrix. This gives possibilities to create complex tissues, just as they appear in nature, with different cell types and controlled histology optimized for your applications.[/vc_column_text][us_separator size=”small”][vc_column_text]

BIOPIXLAR – The unique high-resolution bioprinting platform

The platform includes high-resolution camera and fluorescence microscopy enabling real time monitoring of the printing process. Printing is performed in native cell media, maintaining cell viability and offering direct access for testing drugs.[/vc_column_text][us_separator][us_image image=”17177″ size=”full” align=”center”][us_separator][vc_column_text]

How to use BIOPIXLAR®?

Place the Biopixlar printerhead at a desired spot, and print your cells of interest. The recirculating microfluidic technology enables direct cell patterning and printing, ranging from arrays of single cells to highly complex motifs with multiple cell types. After printing, the cell print is transferred to a cell culture platform allowing for the development of continuous and robust tissue models.[/vc_column_text][us_separator][/vc_column][/vc_row][vc_row][vc_column][us_separator size=”small”][/vc_column][vc_column width=”2/3″][vc_column_text]

ARE YOU INTERESTED IN SCIENTIFIC ANIMATION AND COMMUNICATION?

[/vc_column_text][/vc_column][vc_column width=”1/3″][us_btn label=”Contact us” link=”url:https%3A%2F%2F3dforscience.com%2F%23contact%20_blank||target:%20_blank|”][/vc_column][vc_column][us_separator size=”small”][/vc_column][/vc_row]

ARE YOU INTERESTED IN SCIENTIFIC ANIMATION AND COMMUNICATION?

Related news

High performance sustainable material: Sappi Symbio

High performance sustainable material: Sappi Symbio

High performance sustainable material: Sappi Symbio Sappi is a global company focused on providing dissolving pulp, paper pulp, paper-based and biorefinery solutions to its customers in over 150 countries. They invest in research and development programs, unlocking...

cPass™ technology by GenScript

cPass™ technology by GenScript

cPass™ Technology by GenScript Coronaviruses are a large family of viruses that may cause illness in animals or humans.  In humans, several coronaviruses are known to cause respiratory infections ranging from the common cold to more severe diseases such as Middle East...

B2B device: from breast to bone

B2B device: from breast to bone

B2B Device: From Breast To Bone ABOUT CLIENT: B2B is an EU-funded project that aims to develop a breakthrough technology that for the first time dissects the steps of spontaneous breast cancer metastasis to the bone and captures the 3D complexity of the process. The...